Concepedia

Marvin Gorman

MG

49

Publications

3.2K

Citations

30

H-Index

1953

Active since

Affiliations

Eli Lilly (United States)(Current)

Marvin Gorman is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and biochemistry.

Top concepts

PharmacologyBiochemistryMedicineNatural SciencesBioorganic ChemistryDrug DiscoveryChemistryMicrobiologyMedicinal ChemistryOrganic Chemistry

Publications per year

1953–1978

49

Publications

49

THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

Johnson Is, Armstrong Jg, Marvin Gorman et al. · PubMed · 1963 · 558 citations

Medicinal Chemistry, Vinca Alkaloids, Biochemistry +12

The structure op beauvericin, a new depsipeptide antibiotic toxic to

Robert L. Hamill, C. E. Higgens, Harold E. Boaz et al. · Tetrahedron Letters · 1969 · 363 citations

Antibiotics, Medicine, Structure Op Beauvericin +7

.beta.-Lactam antibiotics from Streptomyces

R. Nagarajan, LaVerne D. Boeck, Marvin Gorman et al. · Journal of the American Chemical Society · 1971 · 270 citations

Altmetric Attention Score, Antimicrobial Chemotherapy, Antibiotic Resistance +16

Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.) V.**Organic Chemical Development and Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Ind.

Gordon H. Svoboda, Norbert Neuss, Marvin Gorman · Journal of the American Pharmaceutical Association (Scientific ed ) · 1959 · 189 citations

Lilly Research Laboratories, Bioorganic Chemistry, Biochemistry +10

Studies in Organic Sulfur Compounds. VI.<sup>1</sup> Cyclic Ethylene and Trimethylene Hemithioketals

Carl Djerassi, Marvin Gorman · Journal of the American Chemical Society · 1953 · 114 citations

Altmetrics, Organic Sulfur Compounds, Chemical Engineering +12

Rows per page

1–5 of 49